Quotes 5-day view Delayed Nasdaq
11/24/2020
11/25/2020
11/27/2020
11/30/2020
12/01/2020
Date
159.28(c)
162.15(c)
164.52(c)
168.73(c)
168.62(c)
Last
377 545
174 824
59 828
178 621
188 336
Volume
+0.50% +1.80% +1.46% +2.56% -0.07% Change
Sales 2020
8,28 M 9,98 M 9,98 M
Net income 2020
-367 M -442 M -442 M
Net cash position 2020
871 M 1 049 M 1 049 M
P/E ratio 2020
-19,6x
Yield 2020
-
Sales 2021
56,2 M 67,7 M 67,7 M
Net income 2021
-334 M -403 M -403 M
Net cash position 2021
647 M 780 M 780 M
P/E ratio 2021
-23,0x
Yield 2021
-
Capitalization
7 550 M 9 013 M 9 095 M
EV / Sales 2020
807x
EV / Sales 2021
123x
Nbr of Employees
330
Free-Float
11,2%
ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto,...
Notations Surperformance© of Ascendis Pharma A/S
Trading Rating : Investor Rating :
All news about ASCENDIS PHARMA A/S
News in other languages on ASCENDIS PHARMA A/S
Chart ASCENDIS PHARMA A/S
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ASCENDIS PHARMA A/S
Short Term Mid-Term Long Term Trends Neutral Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
10
Average target price
161,34 €
Last Close Price
141,35 €
Spread / Highest target
27,5%
Spread / Average Target
14,1%
Spread / Lowest Target
0,45%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
